Keywords: bayer, make, six-year, investment, operations, german, chemical
Bayer To Make Six-Year Investment In US Operations
Article | 09 April 1997
German chemical and pharmaceutical company Bayer is investing around $9billion over a six-year period from 1995 to 2000 in strengthening its operations ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
